Stockholders' Equity and Stock-Based Compensation (Option Activity Under the Company's Stock Plans) (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Options, Outstanding [Roll Forward]
Outstanding at beginning of year (in shares)	15.7	17.6	17.5
Granted, options (in shares)	1.6	2.8	2.6
Exercised, options (in shares)	(2.7)	(1.7)	(1.8)
Cancelled/forfeited, options (in shares)	(0.5)	(0.9)	(0.7)
Adjustment due to Veralto Separation (in shares)		(2.1)
Outstanding at end of year (in shares)	14.1	15.7	17.6
Vested and expected to vest as of end of year (in shares)	13.9
Vested as of end of year (in shares)	8.7
Weighted Average Exercise Price, Outstanding [Roll Forward]
Outstanding as of beginning of year (in usd per share)	$ 147.02	$ 131.98	$ 112.91
Granted (in usd per share)	252.97	218.69	236.68
Exercised (in usd per share)	99.82	83.13	77.27
Cancelled/forfeited (in usd per share)	234.19	178.71	184.80
Adjustment due to Veralto Separation (in usd per share)		154.67
Outstanding as of end of year (in usd per share)	164.99	$ 147.02	$ 131.98
Vested and expected to vest as of end of year, weighted average exercise price (in usd per share)	164.15
Vested as of end of year, weighted average exercise price (in usd per share)	$ 129.51
Outstanding at end of year, weighted average remaining contractual term (in years)	5 years
Vested and expected to vest at end of year, weighted average remaining contractual term (in years)	5 years
Vested at end of year, weighted average remaining contractual term (in years)	4 years
Outstanding as of end of year, aggregate intrinsic value	$ 973
Vested and expected to vest as of end of year, aggregate intrinsic value	971
Vested as of end of year, aggregate intrinsic value	$ 893